Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develo...
Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market | CMND Stock News
Pre-market hot trades in US stocks: Clearmind Medicine pre-market down 7.03%; Corning pre-market down 3.40%
Clearmind Medicine releases update on intranasal MEAI formulation retention study
Clearmind Medicine posts update on CMND-100 first-in-human trial webinar insights
Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial | CMND Stock News
Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative | CMND Stock News